Bank of New York Mellon Corp Has $19.12 Million Stock Position in Sotera Health (NASDAQ:SHC)

Bank of New York Mellon Corp cut its holdings in Sotera Health (NASDAQ:SHC) by 1.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,014,964 shares of the company’s stock after selling 15,789 shares during the quarter. Bank of New York Mellon Corp’s holdings in Sotera Health were worth $19,122,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. increased its stake in shares of Sotera Health by 7.6% in the 1st quarter. BlackRock Inc. now owns 6,252,520 shares of the company’s stock valued at $135,429,000 after acquiring an additional 439,762 shares in the last quarter. ArrowMark Colorado Holdings LLC increased its stake in Sotera Health by 57.1% in the first quarter. ArrowMark Colorado Holdings LLC now owns 4,787,776 shares of the company’s stock valued at $85,749,000 after purchasing an additional 1,739,304 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Sotera Health by 402.0% during the fourth quarter. AQR Capital Management LLC now owns 3,477,868 shares of the company’s stock valued at $28,275,000 after purchasing an additional 2,785,022 shares during the period. State Street Corp boosted its position in shares of Sotera Health by 4.5% during the 1st quarter. State Street Corp now owns 2,767,404 shares of the company’s stock worth $49,563,000 after purchasing an additional 120,366 shares in the last quarter. Finally, Hawk Ridge Capital Management LP acquired a new stake in shares of Sotera Health in the 1st quarter valued at about $33,017,000. 88.89% of the stock is currently owned by institutional investors.

Sotera Health Trading Down 0.4 %

Shares of Sotera Health stock opened at $12.95 on Monday. The company has a market capitalization of $3.66 billion, a P/E ratio of -11.77 and a beta of 2.26. The stock has a fifty day simple moving average of $14.14 and a 200 day simple moving average of $15.69. Sotera Health has a 12-month low of $5.84 and a 12-month high of $19.40. The company has a current ratio of 2.59, a quick ratio of 2.40 and a debt-to-equity ratio of 6.06.

Analysts Set New Price Targets

A number of research firms recently weighed in on SHC. Royal Bank of Canada dropped their price target on Sotera Health from $22.00 to $20.00 and set an “outperform” rating on the stock in a research note on Thursday, November 2nd. KeyCorp lowered their target price on Sotera Health from $24.00 to $23.00 and set an “overweight” rating on the stock in a research report on Friday, August 4th. Finally, Barclays decreased their price target on shares of Sotera Health from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Thursday, November 2nd. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and an average price target of $18.17.

About Sotera Health

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services.